問卷

TPIDB > Search Result

Search Result

篩選

List

5239Cases

2009-06-01 - 2012-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2008-12-15 - 2010-12-31

Phase III

Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer’s Disease.
  • Condition/Disease

    Alzheimer's disease

  • Test Drug

    Donepezil SR 23mg

Participate Sites
3Sites

Terminated3Sites

2008-10-01 - 2012-04-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Study ended7Sites

2007-11-01 - 2012-11-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2008-09-01 - 2009-07-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2008-10-01 - 2010-10-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2007-11-01 - 2010-03-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2007-08-01 - 2009-08-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2007-10-31 - 2011-10-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites